Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical Oncology/Epidemiology
  • Published:

Clinical Oncology/Epidemiology

The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study

Abstract

The completeness of cancer registration in England for the period 1968-85 has been assessed in a cohort of 17,000 women who reported malignancies directly to the investigators. Of 325 cancers reported, 281 (86.5%) had been registered by mid-1987. Under-registration varied considerably between regional cancer registries. Eight (18%) of the 44 unregistered cancers were treated in private hospitals. Under-registration also varied considerably with cancer site: only 8% of 150 breast cancers were not registered, and at sites accounting for 79% of all tumours, under-registration was less than 15%; however, 40% of melanomas (20 cases) and 50% of lung cancers (6 cases) were not registered. Of 281 registered tumours, only 219 (78%) were notified to the investigators from the NHSCR at Southport, with a median lag-time of 2.5 years since diagnosis. There has been a tendency for notification of registered cancers to the investigator to become more prompt but less complete.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Villard-Mackintosh, L., Coleman, M. & Vessey, M. The completeness of cancer registration in England: an assessment from the Oxford-FPA contraceptive study. Br J Cancer 58, 507–511 (1988). https://doi.org/10.1038/bjc.1988.252

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1988.252

This article is cited by

Search

Quick links